Isoniazid Induced Cutaneous Leukocytoclastic Vasculitis in Extra Pulmonary Tuberculosis (Pott's Spine): A Case Report

被引:5
作者
Bondalapati, Sowmya [1 ]
Rao, Dharma, V [1 ]
Rampure, Dilip [1 ]
Rao, Rama S. [1 ]
机构
[1] Mamata Med Coll, Dept Gen Med, Khammam, Andhra Pradesh, India
关键词
Anti tuberculosis drugs; Isoniazid; Leucocytoclastic vasculitis; Pott's spine;
D O I
10.7860/JCDR/2014/9000.4688
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Anti-tuberculosis drugs frequently result in cutaneous adverse reactions but Isoniazid is known to have least toxic potential for cutaneous reactions. We report a rare case of Isoniazid induced cutaneous leucocytoclastic vasculitis. A 64-year-old male was diagnosed to have Pott's spine with multiple vertebral body involvement (D8-12 vertebrae). Subsequently, he was treated with first line anti-TB drugs i. e., Isoniazid, Rifampicin, Pyrazinamide and Ethambutol. On the fourth day of treatment with Anti Tuberculosis Treatment (ATT), the patient developed an erythematosus rash over right upper limb not associated with itching or pain, non-blanchable macules and papules over bilateral shins on lower limbs, petechiae on both forearms and hyper pigmented, scaly rash over right axilla and buttocks. The skin biopsy report was consistent with cutaneous leukocytoclastic vasculitis. Although rare, Isoniazid among anti-tuberculosis drugs should be considered as potential cause of drug-induced cutaneous leukocytoclastic vasculitis in the differential diagnosis of erythematosus rash with petechiae.
引用
收藏
页码:MD3 / MD5
页数:3
相关论文
共 10 条
[1]   Cutaneous tuberculosis: Diagnosis and treatment [J].
Barbagallo J. ;
Tager P. ;
Ingleton R. ;
Hirsch R.J. ;
Weinberg J.M. .
American Journal of Clinical Dermatology, 2002, 3 (5) :319-328
[2]  
Carvalho Maurício, 2008, J. bras. pneumol., V34, P745
[3]   CUTANEOUS VASCULITIS ASSOCIATED WITH TUBERCULOSIS AND ITS TREATMENT [J].
CHAN, CHS ;
CHONG, YW ;
SUN, AJM ;
HOHEISEL, GB .
TUBERCLE, 1990, 71 (04) :297-300
[4]   Small-vessel vasculitis [J].
Jennette, JC ;
Falk, RJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (21) :1512-1523
[5]   CIRCULATING IMMUNE-COMPLEXES IN TUBERCULOSIS [J].
JOHNSON, NM ;
MCNICOL, MW ;
BURTONKEE, EJ ;
MOWBRAY, JF .
THORAX, 1981, 36 (08) :610-617
[6]   Cutaneous leukocytoclastic vasculitis due to anti-tuberculosis medications, rifampin and pyrazinamide [J].
Kim, Joo-Hee ;
Moon, Jun-Ii ;
Kim, Jeong Eun ;
Choi, Gil-Soon ;
Park, Hae-Sim ;
Ye, Young-Min ;
Yim, Hyunee .
ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2010, 2 (01) :55-58
[7]   A METHOD FOR ESTIMATING THE PROBABILITY OF ADVERSE DRUG-REACTIONS [J].
NARANJO, CA ;
BUSTO, U ;
SELLERS, EM ;
SANDOR, P ;
RUIZ, I ;
ROBERTS, EA ;
JANECEK, E ;
DOMECQ, C ;
GREENBLATT, DJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (02) :239-245
[8]   Risk factors for side-effects of isoniazid, rifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosis [J].
Schaberg, T ;
Rebhan, K ;
Lode, H .
EUROPEAN RESPIRATORY JOURNAL, 1996, 9 (10) :2026-2030
[9]  
Sneller MC, 2005, HARRISONS PRINCIPLES, P2002
[10]  
Tan W C, 2007, Med J Malaysia, V62, P143